Chris Baggett, PhD
About
Dr. Baggett’s research experience includes leading and supporting work related to chronic disease observational studies, surveillance systems, and use of large data sets such as administrative claims and medical records. Given this experience his research interests are in the methodology and practical application of insurance claims and electronic health record (EHR) data in cancer epidemiology and health services research.
Dr. Baggett is the Faculty Director of the Cancer Information & Population Health Resource (CIPHR) within the UNC Lineberger Comprehensive Cancer Center. He supervises a diverse staff of cancer outcomes researchers. The CIPHR team has developed a population science resource that has linked North Carolina state cancer registry data to person-level data from multiple insurers, epidemiologic cohort data, and community-level contextual data. He oversees all study design, analytic, and data management aspects of CIPHR projects.
Chris Baggett in the Gillings News
Key Publications
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Spees LP, Wheeler SB, Jackson BE, Baggett CD, Wilson LE, Greiner MA, Kaye DR, Zhang T, George D, Scales CD Jr, Pritchard JE, Leapman M, Gross CP, Dinan MA (1970). Cancer Med, 10(19), 6653-6665.
Sociodemographic inequities in tobacco retailer density: Do neighboring places matter? Kong AY, Delamater PL, Gottfredson NC, Ribisl KM, Baggett CD, Golden SD (2021). Health Place, 71(102653).
Trends in the Number and Type of Tobacco Product Retailers, United States, 2000-2017. Golden SD, Baggett CD, Kuo TM, Kong AY, Delamater PL, Tao VQ, Ribisl KM (1970). Nicotine Tob Res, 150.
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell Carcinoma. Wheeler SB, Spees LP, Jackson BE, Baggett CD, Wilson LE, Greiner MA, Kaye DR, Zhang T, George D, Scales CD Jr, Pritchard JE, Dinan MA (1970). JCO Oncol Pract, OP2001082.
Understanding and identifying immortal-time bias in surgical health services research: An example using surgical resection of stage IV breast cancer. Jackson BE, Greenup RA, Strassle PD, Deal AM, Baggett CD, Lund JL, Reeder-Hayes KE (2021). Surg Oncol, 37(101539).
Cost- effectiveness of endocrine therapy versus radiotherapy versus combined endocrine and radiotherapy for older women with early-stage breast cancer. Wheeler SB, Rotter JS, Baggett CD, Zhou X, Zagar T, Reeder-Hayes KE (2021). J Geriatr Oncol, 12(5), 741-748.
Staff/Administrative Duties
Faculty Director, Cancer Information & Population Health Resource
